IBDEI0GS ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,689,0)
 ;;=GU / RENAL^7^69
 ;;^UTILITY(U,$J,358.4,690,0)
 ;;=WOMEN'S HEALTH^21^69
 ;;^UTILITY(U,$J,358.4,691,0)
 ;;=HEMATOLOGY/ONCOLOGY^8^69
 ;;^UTILITY(U,$J,358.4,692,0)
 ;;=INFECTIOUS DISEASE^10^69
 ;;^UTILITY(U,$J,358.4,693,0)
 ;;=DERMATOLOGY^3^69
 ;;^UTILITY(U,$J,358.4,694,0)
 ;;=HISTORY OF ILLNESS^9^69
 ;;^UTILITY(U,$J,358.4,695,0)
 ;;=PREVENTIVE HEALTH/SCREENINGS^17^69
 ;;^UTILITY(U,$J,358.4,696,0)
 ;;=INJURY/TRAUMA^11^69
 ;;^UTILITY(U,$J,358.4,697,0)
 ;;=SIGNS, SYMPTOMS, CONDITIONS^20^69
 ;;^UTILITY(U,$J,358.4,698,0)
 ;;=SEXUAL TRAUMA^19^69
 ;;^UTILITY(U,$J,358.4,699,0)
 ;;=PAIN^16^69
 ;;^UTILITY(U,$J,358.4,700,0)
 ;;=OTHER REASONS^15^69
 ;;^UTILITY(U,$J,358.4,701,0)
 ;;=CAUSES OF INJURY (SECONDARY ONLY)^2^69
 ;;^UTILITY(U,$J,358.4,702,0)
 ;;=OUTPT NEW PATIENT^3^70
 ;;^UTILITY(U,$J,358.4,703,0)
 ;;=OUTPT ESTABLISHED PATIENT^2^70
 ;;^UTILITY(U,$J,358.4,704,0)
 ;;=OUTPT CONSULTATIONS^4^70
 ;;^UTILITY(U,$J,358.4,705,0)
 ;;=NURSING VISIT ONLY^1^70
 ;;^UTILITY(U,$J,358.4,706,0)
 ;;=INITIAL OBSERVATION^9^70
 ;;^UTILITY(U,$J,358.4,707,0)
 ;;=SAME DAY ADM/DISCHARGE^12^70
 ;;^UTILITY(U,$J,358.4,708,0)
 ;;=INPT CONSULTATIONS^5^70
 ;;^UTILITY(U,$J,358.4,709,0)
 ;;=INITIAL HOSPITAL CARE^6^70
 ;;^UTILITY(U,$J,358.4,710,0)
 ;;=SUBSEQUENT HOSPITAL CARE^7^70
 ;;^UTILITY(U,$J,358.4,711,0)
 ;;=HOSPITAL CARE D/C SERVICES^8^70
 ;;^UTILITY(U,$J,358.4,712,0)
 ;;=SUBSEQUENT OBSERVATION CARE^10^70
 ;;^UTILITY(U,$J,358.4,713,0)
 ;;=OBSERVATION CARE D/C SERVICES^11^70
 ;;^UTILITY(U,$J,358.4,714,0)
 ;;=PROLONGED SERVICES^13^70
 ;;^UTILITY(U,$J,358.4,715,0)
 ;;=DIALYSIS ENCOUNTER^1^71
 ;;^UTILITY(U,$J,358.4,716,0)
 ;;=PERITONEAL DIALYSIS ENCOUNTER^2^71
 ;;^UTILITY(U,$J,358.4,717,0)
 ;;=CARDIOLOGY^3^71
 ;;^UTILITY(U,$J,358.4,718,0)
 ;;=COMPLICATIONS/OTHER^4^71
 ;;^UTILITY(U,$J,358.4,719,0)
 ;;=CYSTIC KIDNEY DISEASE^5^71
 ;;^UTILITY(U,$J,358.4,720,0)
 ;;=DIABETES/DIABETIC RENAL DISEASE^6^71
 ;;^UTILITY(U,$J,358.4,721,0)
 ;;=FLUID/ELECTROLYTES DISORDER^7^71
 ;;^UTILITY(U,$J,358.4,722,0)
 ;;=GENERAL SYMPTOMS^8^71
 ;;^UTILITY(U,$J,358.4,723,0)
 ;;=GENITAL/URINARY^9^71
 ;;^UTILITY(U,$J,358.4,724,0)
 ;;=HEMATOLOGY^10^71
 ;;^UTILITY(U,$J,358.4,725,0)
 ;;=HYPERTENSION PRIMARY^11^71
 ;;^UTILITY(U,$J,358.4,726,0)
 ;;=HYPERTENSION SECONDAY^12^71
 ;;^UTILITY(U,$J,358.4,727,0)
 ;;=HYPERTENSIVE HEART/RENAL^13^71
 ;;^UTILITY(U,$J,358.4,728,0)
 ;;=INFECTIOUS DISEASE^14^71
 ;;^UTILITY(U,$J,358.4,729,0)
 ;;=NEPHRITIS GLOMERULONEPHRITIS^15^71
 ;;^UTILITY(U,$J,358.4,730,0)
 ;;=NEPHRITIS INTERSTITIAL^16^71
 ;;^UTILITY(U,$J,358.4,731,0)
 ;;=NEPHROTIC SYNDROME^17^71
 ;;^UTILITY(U,$J,358.4,732,0)
 ;;=OBSTRUCTIVE UROPATHY/STONES^18^71
 ;;^UTILITY(U,$J,358.4,733,0)
 ;;=ONCOLOGY^19^71
 ;;^UTILITY(U,$J,358.4,734,0)
 ;;=TRANSPLANTATION^21^71
 ;;^UTILITY(U,$J,358.4,735,0)
 ;;=ESTABLISHED PATIENT^1^72
 ;;^UTILITY(U,$J,358.4,736,0)
 ;;=CONSULTATIONS/OPINIONS^2^72
 ;;^UTILITY(U,$J,358.4,737,0)
 ;;=NEWPATIENTS^3^72
 ;;^UTILITY(U,$J,358.4,738,0)
 ;;=CEREBROVASCULAR DIS^2^73
 ;;^UTILITY(U,$J,358.4,739,0)
 ;;=SEIZURES/EPILEPSY/SPELLS^5^73
 ;;^UTILITY(U,$J,358.4,740,0)
 ;;=HEADACHE^6^73
 ;;^UTILITY(U,$J,358.4,741,0)
 ;;=DIZZINESS^3^73
 ;;^UTILITY(U,$J,358.4,742,0)
 ;;=NEURODEGENERATIVE DIS^9^73
 ;;^UTILITY(U,$J,358.4,743,0)
 ;;=PAIN^12^73
 ;;^UTILITY(U,$J,358.4,744,0)
 ;;=NEUROPATHIES^10^73
 ;;^UTILITY(U,$J,358.4,745,0)
 ;;=ENCEPALOPATHY^4^73
 ;;^UTILITY(U,$J,358.4,746,0)
 ;;=SPINAL CONDITIONS^14^73
 ;;^UTILITY(U,$J,358.4,747,0)
 ;;=VISION DISTURBANCES^16^73
 ;;^UTILITY(U,$J,358.4,748,0)
 ;;=MOVEMENT DISORDERS^15^73
 ;;^UTILITY(U,$J,358.4,749,0)
 ;;=OTHER^13^73
 ;;^UTILITY(U,$J,358.4,750,0)
 ;;=CARDIAC DISORDERS^1^73
 ;;^UTILITY(U,$J,358.4,751,0)
 ;;=NEOPLASMS^8^73
 ;;^UTILITY(U,$J,358.4,752,0)
 ;;=SYMPTOMS^17^73
 ;;^UTILITY(U,$J,358.4,753,0)
 ;;=NEUROLOGY/SEIZURE^1^74
 ;;^UTILITY(U,$J,358.4,754,0)
 ;;=EEG^2^74
 ;;^UTILITY(U,$J,358.4,755,0)
 ;;=SLEEP TESTING^3^74
 ;;^UTILITY(U,$J,358.4,756,0)
 ;;=MUSCLE TESTING/EMG^4^74
 ;;^UTILITY(U,$J,358.4,757,0)
 ;;=EVOKED POTENTIAL^5^74
 ;;^UTILITY(U,$J,358.4,758,0)
 ;;=BIOPSY^5.5^74
 ;;^UTILITY(U,$J,358.4,759,0)
 ;;=AUTONOMIC FUNCTION TESTS^8^74
 ;;^UTILITY(U,$J,358.4,760,0)
 ;;=ESTABLISHED PATIENT^2^75
 ;;^UTILITY(U,$J,358.4,761,0)
 ;;=INJECTIONS/MEDICATION^10^76
 ;;^UTILITY(U,$J,358.4,762,0)
 ;;=OTHER^11^76
 ;;^UTILITY(U,$J,358.4,763,0)
 ;;=ALLERGY INJECTION^1^76
 ;;^UTILITY(U,$J,358.4,764,0)
 ;;=INJECTION ADMINISTRATION^9^76
 ;;^UTILITY(U,$J,358.4,765,0)
 ;;=IMMUNIZATION ADMINISTRATION ^6^76
 ;;^UTILITY(U,$J,358.4,766,0)
 ;;=CATHETER^2^76
 ;;^UTILITY(U,$J,358.4,767,0)
 ;;=CATH FLUSHES^3^76
 ;;^UTILITY(U,$J,358.4,768,0)
 ;;=PFT^12^76
 ;;^UTILITY(U,$J,358.4,769,0)
 ;;=EKG/HOLTER MONITOR^5^76
 ;;^UTILITY(U,$J,358.4,770,0)
 ;;=IMMUNIZATIONS^7^76
 ;;^UTILITY(U,$J,358.4,771,0)
 ;;=INFUSIONS^8^76
 ;;^UTILITY(U,$J,358.4,772,0)
 ;;=PICC^13^76
 ;;^UTILITY(U,$J,358.4,773,0)
 ;;=SMOKING CESSATION^14^76
 ;;^UTILITY(U,$J,358.4,774,0)
 ;;=CHEMO AND OTH COMPLEX DRUGS^4^76
 ;;^UTILITY(U,$J,358.4,775,0)
 ;;=SIGNS AND SYMPTOMS^1^77
 ;;^UTILITY(U,$J,358.4,776,0)
 ;;=CARDIO/VASCULAR^2^77
 ;;^UTILITY(U,$J,358.4,777,0)
 ;;=ENDOCRINE, METOBOLIC, NUTRITIONAL^4^77
 ;;^UTILITY(U,$J,358.4,778,0)
 ;;=EYES, EARS, & NOSE^5^77
 ;;^UTILITY(U,$J,358.4,779,0)
 ;;=GASTROINTESTINAL^6^77
 ;;^UTILITY(U,$J,358.4,780,0)
 ;;=GENITOURINARY & RENAL^7^77
 ;;^UTILITY(U,$J,358.4,781,0)
 ;;=MUSCULOSKETAL^9^77
 ;;^UTILITY(U,$J,358.4,782,0)
 ;;=NEUROLOGY^10^77
 ;;^UTILITY(U,$J,358.4,783,0)
 ;;=PULMONARY/RESPIRATORY^14^77
 ;;^UTILITY(U,$J,358.4,784,0)
 ;;=PSYCHIATRIC^15^77
 ;;^UTILITY(U,$J,358.4,785,0)
 ;;=SKIN^16^77
 ;;^UTILITY(U,$J,358.4,786,0)
 ;;=IMMUNIZATIONS^8^77
 ;;^UTILITY(U,$J,358.4,787,0)
 ;;=OTHER^12^77
 ;;^UTILITY(U,$J,358.4,788,0)
 ;;=PREVENTIVE MEDICINE CODES^13^77
 ;;^UTILITY(U,$J,358.4,789,0)
 ;;=NURSING MISCELLANEOUS^11^77
 ;;^UTILITY(U,$J,358.4,790,0)
 ;;=COUNSELING^3^77
 ;;^UTILITY(U,$J,358.4,791,0)
 ;;=CONTACT W/ HAZARDOUS SUBSTANCES^.5^77
 ;;^UTILITY(U,$J,358.4,792,0)
 ;;=GYN PROCEDURES^1^78
 ;;^UTILITY(U,$J,358.4,793,0)
 ;;=INJECTIONS^3^78
 ;;^UTILITY(U,$J,358.4,794,0)
 ;;=ADMINISTRATION OF INJECTION^4^78
 ;;^UTILITY(U,$J,358.4,795,0)
 ;;=FOREIGN BODY^6^78
 ;;^UTILITY(U,$J,358.4,796,0)
 ;;=UA/FINGERSTICK^8^78
 ;;^UTILITY(U,$J,358.4,797,0)
 ;;=FLUSHES^5^78
 ;;^UTILITY(U,$J,358.4,798,0)
 ;;=DESTRUCTION OF LESIONS^2^78
 ;;^UTILITY(U,$J,358.4,799,0)
 ;;=MATERNAL CARE^7^78
 ;;^UTILITY(U,$J,358.4,800,0)
 ;;=NEW PATIENT^2^79
 ;;^UTILITY(U,$J,358.4,801,0)
 ;;=ESTABLISHED PATIENT^1^79
 ;;^UTILITY(U,$J,358.4,802,0)
 ;;=CONSULTATIONS^3^79
 ;;^UTILITY(U,$J,358.4,803,0)
 ;;=GASTROINTESTINAL^3^80
 ;;^UTILITY(U,$J,358.4,804,0)
 ;;=GENITOURINARY & RENAL^2^80
 ;;^UTILITY(U,$J,358.4,805,0)
 ;;=GYNECOLOGICAL/BREAST^1^80
 ;;^UTILITY(U,$J,358.4,806,0)
 ;;=PREGNANCY-COMPLICATIONS^4^80
 ;;^UTILITY(U,$J,358.4,807,0)
 ;;=PREGNANCY-FETAL ABNORMALITY^5^80
 ;;^UTILITY(U,$J,358.4,808,0)
 ;;=PREGNANCY-HYPERTENSION^6^80
 ;;^UTILITY(U,$J,358.4,809,0)
 ;;=PREGNANCY-INFECTIONS BREAST/NIPPLE^7^80
 ;;^UTILITY(U,$J,358.4,810,0)
 ;;=PREGNANCY-LATE PREGNANCY^8^80
 ;;^UTILITY(U,$J,358.4,811,0)
 ;;=PREGNANCY-PUERPERAL INFECTIONS^14^80
 ;;^UTILITY(U,$J,358.4,812,0)
 ;;=PREGNANCY-MULTIPLE GESTATIONS^9^80
 ;;^UTILITY(U,$J,358.4,813,0)
 ;;=PREGNANCY-OTH COMP OF PUERPERIUM^11^80
 ;;^UTILITY(U,$J,358.4,814,0)
 ;;=PREGNANCY-OTHER COMPLICATIONS^10^80
 ;;^UTILITY(U,$J,358.4,815,0)
 ;;=PREGNANCY-OTHER CONDITIONS^12^80
 ;;^UTILITY(U,$J,358.4,816,0)
 ;;=PREGNANCY-PROBLEMS W/ AMNIO/MEMBRANES^13^80
 ;;^UTILITY(U,$J,358.4,817,0)
 ;;=PREGNANCY-PYREXIA^15^80
 ;;^UTILITY(U,$J,358.4,818,0)
 ;;=PREGNANCY-V CODES^16^80
 ;;^UTILITY(U,$J,358.4,819,0)
 ;;=PREGNANCY-VENOUS COMPLICATIONS^17^80
 ;;^UTILITY(U,$J,358.4,820,0)
 ;;=PREGNANCY-VOMITING^18^80
 ;;^UTILITY(U,$J,358.4,821,0)
 ;;=V CODES^19^80
 ;;^UTILITY(U,$J,358.4,822,0)
 ;;=SPECIAL SERVICES^6^81
 ;;^UTILITY(U,$J,358.4,823,0)
 ;;=TREATMENT^7^81
 ;;^UTILITY(U,$J,358.4,824,0)
 ;;=MISCELLANEOUS^5^81
 ;;^UTILITY(U,$J,358.4,825,0)
 ;;=IMMUNIZATIONS^4^81
 ;;^UTILITY(U,$J,358.4,826,0)
 ;;=CHEMO ADMINISTRATION^1^81
 ;;^UTILITY(U,$J,358.4,827,0)
 ;;=CHEMO DRUGS^2^81
 ;;^UTILITY(U,$J,358.4,828,0)
 ;;=OTHER DRUGS^3^81
 ;;^UTILITY(U,$J,358.4,829,0)
 ;;=NEW PATIENT^2^82
 ;;^UTILITY(U,$J,358.4,830,0)
 ;;=ESTABLISHED PATIENT^1^82
 ;;^UTILITY(U,$J,358.4,831,0)
 ;;=CONSULTATIONS^3^82
 ;;^UTILITY(U,$J,358.4,832,0)
 ;;=PROLONGED SERVICES^4^82
 ;;^UTILITY(U,$J,358.4,833,0)
 ;;=ANEMIA^1^83
 ;;^UTILITY(U,$J,358.4,834,0)
 ;;=COAGULATION DISORDERS^4^83
 ;;^UTILITY(U,$J,358.4,835,0)
 ;;=MYELOID NEOPLASMS & DISORDERS^12^83
 ;;^UTILITY(U,$J,358.4,836,0)
 ;;=LYMPHOID NEOPLASMS^9^83
 ;;^UTILITY(U,$J,358.4,837,0)
 ;;=GI NEOPLASMS^7^83
 ;;^UTILITY(U,$J,358.4,838,0)
 ;;=HEAD, NECK & LUNG NEOPLASMS^8^83
 ;;^UTILITY(U,$J,358.4,839,0)
 ;;=MISC. NEOPLASMS^11^83
 ;;^UTILITY(U,$J,358.4,840,0)
 ;;=METASTATIC SITES^10^83
 ;;^UTILITY(U,$J,358.4,841,0)
 ;;=COUNSELING & SCREENING^5^83
 ;;^UTILITY(U,$J,358.4,842,0)
 ;;=GENITOURINARY NEOPLASMS^6^83
 ;;^UTILITY(U,$J,358.4,843,0)
 ;;=BREAST & GYN NEOPLASMS^3^83
 ;;^UTILITY(U,$J,358.4,844,0)
 ;;=ARTIFICIAL OPENING STATUS^2^83
 ;;^UTILITY(U,$J,358.4,845,0)
 ;;=PERSONAL HX OF CANCER^15^83
 ;;^UTILITY(U,$J,358.4,846,0)
 ;;=NEOPLASMS OF UNCERTAIN BEHAVIOR^13^83
 ;;^UTILITY(U,$J,358.4,847,0)
 ;;=NEOPLASMS OF UNSPECIFIED NATURE^14^83
 ;;^UTILITY(U,$J,358.4,848,0)
 ;;=INJECTION/ASPIRATION^2^84
 ;;^UTILITY(U,$J,358.4,849,0)
 ;;=FRACTURE DISLOCATION^3^84
 ;;^UTILITY(U,$J,358.4,850,0)
 ;;=APPLICATION CAST^4^84
 ;;^UTILITY(U,$J,358.4,851,0)
 ;;=APPLICATION SPLINTS^5^84
 ;;^UTILITY(U,$J,358.4,852,0)
 ;;=OTHER/REMOVAL/REVISION^6^84
 ;;^UTILITY(U,$J,358.4,853,0)
 ;;=SUPPLIES/SOFT GOODS^7^84
 ;;^UTILITY(U,$J,358.4,854,0)
 ;;=SUPPLIES/DRUGS^8^84
 ;;^UTILITY(U,$J,358.4,855,0)
 ;;=REPAIR/CLOSURE^9^84
 ;;^UTILITY(U,$J,358.4,856,0)
 ;;=NEW PATIENT^2^85
